<!DOCTYPE html>
<html lang="en">
<head>
<title>Invenia™ ABUS 2.0</title>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=0, minimal-ui">
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="description" content="" />
    <meta name="keywords" content="">
    <meta name="author" content="" />

    <!-- Favicon icon -->
   <link rel="icon" type="image/png" sizes="32x32" href="images/favicon-32x32.png">
     <link rel="icon" type="image/png" sizes="16x16" href="images/favicon-16x16.png">
    <!-- fontawesome icon -->
   <style type="text/css">
	@font-face{ 
			font-family: 'GEInspiraSans-Regular';
			src: url('https://gehc.landingbox.net/landingpage/medschool-us-benefits-en-anz-lp1/fonts/GEInspiraSans/GEInspiraSans-Regular.eot'); /* IE9 Compat Modes */
			src: url('https://gehc.landingbox.net/landingpage/medschool-us-benefits-en-anz-lp1/fonts/GEInspiraSans/GEInspiraSans-Regular.eot?#iefix') format('embedded-opentype'), /* IE6-IE8 */
				url('https://gehc.landingbox.net/landingpage/medschool-us-benefits-en-anz-lp1/fonts/GEInspiraSans/GEInspiraSans-Regular.woff') format('woff'), /* Modern Browsers */
				url('https://gehc.landingbox.net/landingpage/medschool-us-benefits-en-anz-lp1/fonts/GEInspiraSans/GEInspiraSans-Regular.ttf') format('truetype'), /* Safari, Android, iOS */
				url('https://gehc.landingbox.net/landingpage/medschool-us-benefits-en-anz-lp1/fonts/GEInspiraSans/GEInspiraSans-Regular.svg#GEInspiraSans-Bold') format('svg'); /* Legacy iOS */
			font-style: normal;
			font-weight: normal;
			text-rendering: optimizeLegibility;
			}
body{font-family: 'GEInspiraSans-Regular',GEInspiraSans !important;font-size:16px;margin: 0;}
.container{max-width: 1280px;margin: 0 auto;}
.row1-bnr{background: url(./images/LP_background_01.jpg) center top no-repeat;background-size: cover;float: left;
    width: 100%;}
.row-3{background: url(./images/LP_background_03.jpg) center top no-repeat;background-size: cover;}

.row1-head{width:100%;float:left}.form-area{color:#000;background:#fff;padding:10px 20px;border-radius:10px;margin:10px 5px}.logo{float:left;padding:20px 0;width:60px}div.footer{background:#fff;color:#63666a;padding-top:50px;padding-bottom:50px;font-size:.8em;border-top:1px solid #dadada;float:left;width:100%}.footer-row{display:flex;justify-content:space-between;align-items:center;float:left;width:100%}.social-icons{position:relative;display:flex;justify-content:center;align-items:center;margin:10px 0;flex-wrap:wrap}.social-icons li a{font-size:2rem;color:#fff;margin:0 10px;display:inline-block}.social-icons li{list-style:none}.ftr-top-space{border-bottom:1px solid #dadada;margin-bottom:25px}.row-3{text-align:center;float:left;width:100%;padding:100px 0}.row-3 img{padding-bottom:10px}.row-3 h2{color:#fff;font-weight:800;font-size:45px;margin:10px 0}.row-3 p{color:#fff;margin:10px 0}.row1-ctnt{color:#fff;float:left;width:100%;display:flex}.row1-left{float:left;width:60%}.row1-right{float:left;width:40%}.row1-left h3{color:#ab89a2;font-size:40px;padding-bottom:50px}.row1-left h2{color:#ab89a2;font-size:60px;margin:0}.row1-left p{color:#6d6e71;margin:0;font-size:32px;font-weight:lighter}.row2-cnt{float:left;width:35%;padding:11% 0}.row2-cnt h2{color:#cd9fb6;font-size:48px;line-height:40px;margin:25px 0}.row2-cnt p{color:#6d6e71;margin:10px 0;font-size:22px}.foot-note{padding-bottom:50px}.flower-img{float:right;position:relative;bottom:137px}.machine{float:right;position:relative;left:250px;bottom:34px;width:55%}.row-2{float:left;width:100%;display:flex;height:619px}.row2-img{float:left;width:65%}@media only screen and (min-width:0px) and (max-width:359px){.row1-bnr{padding:0 10px;width:auto}.row1-ctnt{flex-direction:column}.row1-left{width:100%}.row1-right{width:100%}.row-2{padding:20px 10px;background-position-x:left;height:auto;width:auto}.row2-cnt{width:100%;padding:0}.row2-cnt h2{font-size:35px;margin:0}.row2-cnt p{font-size:20px}.row-3 img{width:100%}.row-3{width:auto;padding:20px 10px}.row-3 h2{font-size:30px}div.footer{padding:20px 10px;width:auto}.logo-ftr{width:75%}.flower-img{display:none}.machine{float:left;position:relative;left:0;bottom:0;width:75%;padding:10px 0}.row2-img img{width:100%}.row1-left h3{font-size:32px;padding-bottom:5px}.row1-left h2{font-size:39px}.row1-left p{font-size:24px}.mc-cntrpl{display:flex;align-items:center;justify-content:center}.row2-img{width:100%}}@media only screen and (min-width:360px) and (max-width:767px){.row1-bnr{padding:0 10px;width:auto}.row1-ctnt{flex-direction:column}.row1-left{width:100%}.row1-right{width:100%}.row-2{padding:10px 10px;background-position-x:left;height:auto;width:auto}.row2-cnt{width:100%;padding:0}.row2-cnt h2{font-size:35px;margin:0}.row2-cnt p{font-size:20px}.row-3 img{width:100%}.row-3{width:auto;padding:10px 10px}.row-3 h2{font-size:30px}div.footer{padding:10px 10px;width:auto}.logo-ftr{width:75%}.flower-img{display:none}.machine{float:left;position:relative;left:0;bottom:0;width:75%;padding:10px 0}.row2-img img{width:100%}.row1-left h3{font-size:32px;padding-bottom:5px}.row1-left h2{font-size:39px}.row1-left p{font-size:24px}.mc-cntrpl{display:flex;align-items:center;justify-content:center}.row2-img{width:100%}}@media only screen and (min-width:768px) and (max-width:1023px){.row1-bnr{width:auto;padding:0 10px}.row1-ctnt{flex-direction:column}.row1-left{width:100%}.row1-right{width:100%}.machine{float:right;position:relative;left:148px;bottom:43px;width:45%}.flower-img{float:right;position:relative;bottom:137px;width:30%;right:72px}.row-2{flex-direction:column;padding:0 10px;width:auto}.row2-cnt{width:100%;width:auto;padding:10px 0}.row2-img{width:100%}.container{margin:0}.row2-img img{width:100%}.row-3 img{width:100%}.row-3{width:auto;padding:100px 10px}div.footer{width:97%;padding-left:10px;padding-right:10px}}@media only screen and (min-device-width:1024px) and (max-device-width:1366px) and (-webkit-min-device-pixel-ratio:2) and (orientation:portrait){.row1-bnr{width:auto;padding:0 10px}.flower-img{float:right;position:relative;bottom:113px;width:26%}.machine{float:right;position:relative;left:157px;bottom:50px;width:45%}.row-2{width:auto;padding-left:10px}.row2-img img{width:100%;height:619px}.row-3 img{width:100%}.row-3{width:98%;padding:100px 10px}div.footer{width:98%;padding:100px 10px}}::-webkit-scrollbar{width:15px}::-webkit-scrollbar-track{background:#fff}::-webkit-scrollbar-thumb{background:#cd9fb5}
   </style>
	  
</head>

<body>
		
		<!-- section1 start	 -->
		<div class="row1-bnr">
			<div class="container">
				<div class="row1-head">
					<img src="images/0_Top-Logo.png" class="logo" alt="logo"/>	
				</div>
				<div class="row1-ctnt">
					<div class="row1-left">
						<h3>Look differently.</h3>
						<h2>Invenia™ ABUS 2.0</h2>
						<p>Automated Breast Ultrasound</p>
						<img src="images/Flower.gif" class="flower-img" alt="flower">
						<div class="mc-cntrpl"><img src="images/machine.png" class="machine" alt="machine"></div>
					</div>
					<div class="row1-right">
						<div class="form-area">
							Thank you for your interest in Invenia™ ABUS 2.0! Please give us your details and 
							we will have our representatives reach out to you.
						</div>
					</div>
				</div>
				</div>
		</div>
		<div class="row-2">
			<div class="container">
				<div class="row2-cnt">
					<h2>Innovative breast</br>cancer screening</h2>
					<p>2D and 3D mammography may miss cancers in dense breasts 1, 2, potentially delaying diagnosis in these women. Both dense breast tissue and cancer appear white on a mammogram, creating a dangerous camouflage effect and a dilemma for radiologists whose goal is to find breast cancer as early as possible.
					</p>
				</div>
				<div class="row2-img">
					<img src="images/row2_img.jpg" alt="bgimg">
				</div>
			</div>
		</div>
		<div class="row-3">
		<div class="container">
			<a href="https://youtu.be/FJePNTaIIc8" target="_blank"><img src="images/LP_background_03_image.jpg" alt="03background"></a>
			<h2>What are the steps in an Invenia ABUS 2.0 exam?</h2>
			<p>The Invenia ABUS 2.0 acquisition process uses 3D ultrasound technology to comfortably and quickly image women with dense breast tissue. Each exam takes approximately 15 minutes.</p>
		</div>
		</div>
		<!-- section1 end	 -->
		<!-- section7 end	 -->
		<div class="footer">
    		<div class="container">
			<p class="foot-note">1 Mandelson et al. J Natl Cancer Inst 2000; 92:1081–1087.</br>
					2 Tagliafico, Massimo Calabrese et al, Journal of Clinical Oncology 2016 34:16, 1882-1888.
					</p>
    				<div class="footer-row">
	    				<div class="ftr-left">
    						<img class="logo-ftr" src="images/24_Bottom-Logo.png" alt="GE">
	    				</div>
	    				
	    				<div class="ftr-right">
    						<ul class="social-icons">
    							<li>
    								<a href="https://www.facebook.com/GEHealthcare/" target="_blank">
    									<img src="images/fb.png" alt="fb">
    								</a>
    							</li>
    							<li>
    								<a href="https://twitter.com/gehealthcare" target="_blank" >
    									<img src="images/tw.png" alt="tw">
    								</a>
    							</li>
    							<li>
    								<a href="https://www.linkedin.com/company/gehealthcare" target="_blank">
    									<img src="images/in.png" alt="in">
    								</a>
    							</li>
    						</ul>
	    				</div>
    				</div>
				<div class="ftr-top-space"> &nbsp </div>
				<div class="ftr-end">
	    					<p style="text-align: center;">©2022 General Electric Company – All rights reserved. GE, GE Monogram are trademarks of General Electric Company.</p>
				</div>
    		</div>
    	</div>
      <!-- Required Js -->
</body>

</html>
